Bausch Health Companies Inc. BHC.TO
Set alert
As of Nov 2, 4:00 PM ET
- YTD
- +18.05%
- 1 year
- +13.87%
- Open
- 11.56
- Prev close
- 11.47
- Mkt cap
- 4.21B
- Vol
- 920.39K
- Avg vol
- 675.95K
- EPS
- -3.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.14
- High
- 11.67
- Forward P/E
- 1.85
- Beta
- 0.28
- Short ratio
- 8.29
- Inst. own
- 65.23%
- Dividend
- 0.00
- Ex-div date
- Nov 9, 2010
- 50-d avg
- 8.76
- 200-d avg
- 7.91
- 1y target
- 0.00
2Y chart
Events in this range
- Dec 9, 2025Rating: Barclays · — → Equal-Weight
- Jan 7, 2026Rating: Truist Securities · Hold → Hold
- Feb 25, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Apr 27, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 29, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 29, 2026Rating: Jefferies · Hold → Hold
Signals (97)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
Newest 20 of 97.
Key statistics
- Market cap
- 4.21B
- Enterprise value
- 23.51B
- Trailing P/E
- 0.00
- Forward P/E
- 1.85
- PEG ratio
- 0.02
- Price / sales
- 0.38
- Price / book
- 0.00
- EPS (TTM)
- -3.14
- Beta
- 0.28
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -7.57%
- Revenue (TTM)
- 11.11B
- Revenue growth
- 9.70%
- Free cash flow
- 1.64B
- Total cash
- 2.48B
- Total debt
- 20.71B
- Return on equity
- -11040.00%
- Shares outstanding
- 374.27M
- Short % of float
- 1.44%
- 50-day average
- 8.76
- 200-day average
- 7.91
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold7
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 1.32.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Jefferies | main | Hold | Hold |
| Oct 29, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Apr 27, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Feb 25, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Jan 7, 2026 | Truist Securities | main | Hold | Hold |
| Dec 9, 2025 | Barclays | init | — | Equal-Weight |
About Bausch Health Companies Inc.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- bauschhealth.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BHC.TO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| APPIO THOMAS J | Chief Executive Officer | Stock Award(Grant) | Feb 24, 2026 | 3,620,030 |
| CARSON SEANA LYNNE | General Counsel | Sale | Mar 2, 2026 | 616,761 |
| CHARHON JEAN-JACQUES | Chief Financial Officer | Stock Award(Grant) | Feb 24, 2026 | 755,538 |
| KAVANAGH SARAH BALDWIN | Director | Stock Award(Grant) | May 21, 2026 | 282,230 |
| LENAR AIMEE J | Officer | Sale | Aug 18, 2026 | 334,853 |
| MILLER STEVEN D | Director | Stock Award(Grant) | May 15, 2025 | 239,224 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| PAULSON & CO. INC. | 19.57% | 73,255,869 | 824.13M | Jun 29, 2026 |
| Goldentree Asset Management LP | 9.26% | 34,665,731 | 389.99M | Jun 29, 2026 |
| Royal Bank of Canada | 2.89% | 10,832,582 | 121.87M | Jun 29, 2026 |
| Healthcare of Ontario Pension Plan Trust Fund | 2.14% | 8,000,000 | 90.00M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 1.99% | 7,465,468 | 83.99M | Jun 29, 2026 |
| Goldman Sachs Group Inc | 1.66% | 6,225,131 | 70.03M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 1.01% | 3,762,192 | 42.32M | Jul 30, 2026 |
| VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 0.66% | 2,481,313 | 27.91M | Jun 29, 2026 |
| SCHWAB STRATEGIC TRUST-Schwab Fundamental International Equity ETF | 0.43% | 1,617,412 | 18.20M | Aug 30, 2026 |
| VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap | 0.26% | 986,066 | 11.09M | Jul 30, 2026 |
| DFA INVESTMENT TRUST CO-The Canadian Small Company Series | 0.22% | 815,010 | 9.17M | Jul 30, 2026 |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.16% | 594,511 | 6.69M | Jul 30, 2026 |